|
Delayed
Nasdaq
16:00:00 2024-11-19 EST
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 24-11-20 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 24-11-20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Stock exchange
Nasdaq
EXAI 4.840 $
+3.20%
7.31M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +3.20% | ||
| 3 years | +4.09% | ||
| 5 years | -79.88% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
633,498,733
Net sales ()
20,079,000
Net sales (USD)
26,570,419
Number of employees
483
Sales / Employee (GBP)
41,571
Sales / Employee (USD)
55,011
Free-Float
36.87%
Free-Float capitalization (USD)
464,012,513
Indicators
Moving average 5 days
4.882
Moving average 100 days
5.16
Price spread / (MMA5)
+0.88%
Price spread / (MMA100)
+6.61%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | +4.09% | 633M | |
| -2.59% | -5.70% | +40.86% | +83.11% | 72.13B | |
| +3.23% | -13.45% | +6.00% | +55.77% | 49.41B | |
| +1.56% | +2.07% | +5.03% | +33.38% | 47.24B | |
| +0.87% | -7.83% | +296.82% | +657.83% | 40.32B | |
| +0.39% | -0.32% | +29.55% | +30.83% | 42.61B | |
| +1.24% | -1.20% | +0.96% | +103.86% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| +5.32% | +0.11% | -8.77% | -12.81% | 23.13B | |
| +3.78% | +5.71% | +16.43% | -1.77% | 21.09B | |
| Average | +1.46% | -3.52% | +39.44% | +100.46% | 36.69B | |
| Weighted average by Cap. | +0.75% | -4.28% | +46.66% | +118.57% |
Historical Quotes: Exscientia plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 3.8 |  | 7.91 |
| 5 years | 3.8 | | 25.16 |
| 10 years | 3.8 | | 30.38 |
Monthly variations
Annual variations
| 2024 | -24.49% | ||
| 2023 | +20.26% | ||
| 2022 | -73.03% | ||
| 2021 | -27.08% |
- Stock Market
- Stocks
- EXAI Stock
- Quotes Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
